CXCR3 activation by lentivirus infection suppresses neuronal autophagy: Neuroprotective effects of antiretroviral therapy

FASEB Journal

Volumn 23, Issue 9, 2009, Pages 2928-2941

  Zhu, Yu ^a   Vergote, David ^a   Pardo, Carlos ^b   Noorbakhsh, Farshid ^a   McArthur, Justin C ^b   Hollenberg, Morley D ^c   Overall, Christopher M ^d   Power, Christopher ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CXCL12; FIV; HIV; neuroinflammation

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; DIDANOSINE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN TISSUE; COGNITION; DEMENTIA; ENZYME ACTIVATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREACTIVITY; LENTIVIRINAE; LEUKOCYTE ACTIVATION; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS INFECTION; SYNAPTIC TRANSMISSION; VIRUS LOAD;

ANIMALS; ANTI-HIV AGENTS; AUTOPHAGY; BRAIN; CATS; DIDANOSINE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV INFECTIONS; HUMANS; LENTIVIRUS INFECTIONS; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, CXCR3;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 70349349151     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-128819     Document Type: Article

References (64)

1. Rock, R. B., and Peterson, P. K. (2006) Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J. Neuroimmune Pharmacol. 1, 117-126 (Pubitemid 44257487)
2. Fehder, W. P., and Douglas, S. D. (2001) Interactions between the nervous and immune systems. Semin. Clin. Neuropsychiatry 6, 229-240
3. Noorbakhsh, F., Overall, C. M., and Power, C. (2009) Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 32, 88-100
4. Ryan, L. A., Cotter, R. L., Zink, W. E., 2nd, Gendelman, H. E., and Zheng, J. (2002) Macrophages, chemokines and neuronal injury in HIV-1-associated dementia. Cell. Mol. Biol. (Noisy-le-grand) 48, 137-150
5. Hult, B., Chana, G., Masliah, E., and Everall, I. (2008) Neurobiology of HIV. Int. Rev. Psychiatry 20, 3-13
6. Kaul, M., and Lipton, S. A. (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4, 307-318 (Pubitemid 44027720)
7. Carloni, S., Buonocore, G., and Balduini, W. (2008) Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol. Dis. 32, 329-339
8. Yang, D. S., Kumar, A., Stavrides, P., Peterson, J., Peterhoff, C. M., Pawlik, M., Levy, E., Cataldo, A. M., and Nixon, R. A. (2008) Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am. J. Pathol. 173, 665-681
9. Alirezaei, M., Kiosses, W. B., Flynn, C. T., Brady, N. R., and Fox, H. S. (2008) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3, e2906
10. Price, R. W., and Spudich, S. (2008) Antiretroviral therapy and central nervous system HIV type 1 infection. J. Infect. Dis. 197(Suppl. 3), S294-S306 (Pubitemid 351717319)
11. Letendre, S., McCutchan, J. A., and Ellis, R. J. (2008) Neurologic complications of HIV disease and their treatment. Top HIV Med. 16, 15-22
12. Rumbaugh, J. A., and Nath, A. (2006) Developments in HIV neuropathogenesis. Curr. Pharm. Des. 12, 1023-1044
13. Muller, T., Meyer, H. E., Egensperger, R., and Marcus, K. (2008) The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog. Neurobiol. 85, 393-406
14. Zhang, K., McQuibban, G. A., Silva, C., Butler, G. S., Johnston, J. B., Holden, J., Clark-Lewis, I., Overall, C. M., and Power, C. (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6, 1064-1071 (Pubitemid 37186198)
15. Vergote, D., Butler, G. S., Ooms, M., Cox, J. H., Silva, C., Hollenberg, M. D., Jhamandas, J. H., Overall, C. M., and Power, C. (2006) Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 103, 19182-19187 (Pubitemid 350002847)
16. Feldman, E. D., Weinreich, D. M., Carroll, N. M., Burness, M. L., Feldman, A. L., Turner, E., Xu, H., and Alexander, H. R. Jr. (2006) Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells. Ann. Surg. Oncol. 13, 125-133 (Pubitemid 43117654)
17. Garin, A., Tarantino, N., Faure, S., Daoudi, M., Lecureuil, C., Bourdais, A., Debre, P., Deterre, P., and Combadiere, C. (2003) Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors. J. Immunol. 171, 5305-5312 (Pubitemid 37432815)
18. Gupta, S. K., Pillarisetti, K., and Lysko, P. G. (1999) Modulation of CXCR4 expression and SDF-1alpha functional activity during differentiation of human monocytes and macrophages. J. Leukoc. Biol. 66, 135-143 (Pubitemid 29321381)
19. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Marra, F., Romagnani, S., Serio, M., and Romagnani, P. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537-1549 (Pubitemid 36682550)
20. Ehlert, J. E., Addison, C. A., Burdick, M. D., Kunkel, S. L., and Strieter, R. M. (2004) Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J. Immunol. 173, 6234-6240
21. Elder, J. H., Sundstrom, M., de Rozieres, S., de Parseval, A., Grant, C. K., and Lin, Y. C. (2008) Molecular mechanisms of FIV infection. Vet. Immunol. Immunopathol. 123, 3-13
22. Richardson, J., Pancino, G., Merat, R., Leste-Lasserre, T., Moraillon, A., Schneider-Mergener, J., Alizon, M., Sonigo, P., and Heveker, N. (1999) Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J. Virol. 73, 3661-3671 (Pubitemid 29189807)
23. Garg, H., Fuller, F. J., and Tompkins, W. A. (2004) Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion. Virology 321, 274-286 (Pubitemid 38406041)
24. Power, C., Buist, R., Johnston, J. B., Del Bigio, M. R., Ni, W., Dawood, M. R., and Peeling, J. (1998) Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J. Virol. 72, 9109-9115 (Pubitemid 28471855)
25. Fletcher, N. F., Brayden, D. J., Brankin, B., and Callanan, J. J. (2008) Feline immunodeficiency virus infection: a valuable model to study HIV-1 associated encephalitis. Vet. Immunol. Immunopathol. 123, 134-137
26. Zink, M. C., Laast, V. A., Helke, K. L., Brice, A. K., Barber, S. A., Clements, J. E., and Mankowski, J. L. (2006) From mice to macaques-animal models of HIV nervous system disease. Curr. HIV Res. 4, 293-305 (Pubitemid 44027719)
27. Boisse, L., Gill, M. J., and Power, C. (2008) HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol. Clin. 26, 799-819 (Pubitemid 352037443)
28. Power, C., Zhang, K., and van Marle, G. (2004) Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases. J. Neurovirol. 10(Suppl.1), 113-117 (Pubitemid 38325102)
29. Johnston, J. B., Jiang, Y., van Marle, G., Mayne, M. B., Ni, W., Holden, J., McArthur, J. C., and Power, C. (2000) Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity. J. Virol. 74, 7211-7220 (Pubitemid 30613068)
30. Hartmann, K., Donath, A., Beer, B., Egberink, H. F., Horzinek, M. C., Lutz, H., Hoffmann-Fezer, G., Thum, I., and Thefeld, S. (1992) Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet. Immunol. Immunopathol. 35, 167-175 (Pubitemid 23015068)
31. Roth, J. S., McCully, C. M., Balis, F. M., Poplack, D. G., and Kelley, J. A. (1999) 2′-beta-fluoro-2′,3′-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition. Drug Metab. Dispos. 27, 1128-1132
32. Antinori, A., Perno, C. F., Giancola, M. L., Forbici, F., Ippolito, G., Hoetelmans, R. M., and Piscitelli, S. C. (2005) Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma. Clin. Infect. Dis. 41, 1787-1793 (Pubitemid 41759866)
33. St Hillaire, C., Vargas, D., Pardo, C. A., Gincel, D., Mann, J., Rothstein, J. D., McArthur, J. C., and Conant, K. (2005) Aquaporin 4 is increased in association with human immunodeficiency virus dementia: implications for disease pathogenesis. J. Neurovirol. 11, 535-543 (Pubitemid 43123772)
34. Noorbakhsh, F., Vergnolle, N., McArthur, J. C., Silva, C., Vodjgani, M., Andrade-Gordon, P., Hollenberg, M. D., and Power, C. (2005) Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J. Immunol. 174, 7320-7329 (Pubitemid 40705702)
35. Kennedy, J. M., Hoke, A., Zhu, Y., Johnston, J. B., van Marle, G., Silva, C., Zochodne, D. W., and Power, C. (2004) Peripheral neuropathy in lentivirus infection: evidence of inflammation and axonal injury. AIDS 18, 1241-1250 (Pubitemid 38822702)
36. Noorbakhsh, F., Tsutsui, S., Vergnolle, N., Boven, L. A., Shariat, N., Vodjgani, M., Warren, K. G., Andrade-Gordon, P., Hollenberg, M. D., and Power, C. (2006) Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203, 425-435 (Pubitemid 43290851)
37. Clark-Lewis, I., Vo, L., Owen, P., and Anderson, J. (1997) Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. Methods Enzymol. 287, 233-250 (Pubitemid 27430244)
38. Koenig, R. E., Gautier, T., and Levy, J. A. (1986) Unusual intrafamilial transmission of human immunodeficiency virus. Lancet 2, 627 (Pubitemid 16055605)
39. Boven, L. A., van der Bruggen, T., van Asbeck, B. S., Marx, J. J., and Nottet, H. S. (1999) Potential role of CCR5 polymorphism in the development of AIDS dementia complex. FEMS Immunol. Med. Microbiol. 26, 243-247
40. Anthony, I. C., and Bell, J. E. (2008) The neuropathology of HIV/AIDS. Int. Rev. Psychiatry 20, 15-24
41. McQuibban, G. A., Butler, G. S., Gong, J. H., Bendall, L., Power, C., Clark-Lewis, I., and Overall, C. M. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508 (Pubitemid 37383907)
42. Sarkar, S., and Rubinsztein, D. C. (2008) Small molecule enhancers of autophagy for neurodegenerative diseases. Mol. Biosyst. 4, 895-901
43. Bellizzi, M. J., Lu, S. M., and Gelbard, H. A. (2006) Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. J. Neuroimmune Pharmacol. 1, 20-31
44. Datta, D., Flaxenburg, J. A., Laxmanan, S., Geehan, C., Grimm, M., Waaga-Gasser, A. M., Briscoe, D. M., and Pal, S. (2006) Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res. 66, 9509-9518 (Pubitemid 44623649)
45. Aksoy, M. O., Yang, Y., Ji, R., Reddy, P. J., Shahabuddin, S., Litvin, J., Rogers, T. J., and Kelsen, S. G. (2006) CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L909-918 (Pubitemid 43725053)
46. Sacktor, N. (2002) The epidemiology of human immunode- ficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 8(Suppl. 2), 115-121
47. Janssen, R. S., Nwanyanwu, O. C., Selik, R. M., and Stehr-Green, J. K. (1992) Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42, 1472-1476
48. Langford, D., Marquie-Beck, J., de Almeida, S., Lazzaretto, D., Letendre, S., Grant, I., McCutchan, J. A., Masliah, E., and Ellis, R. J. (2006) Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J. Neurovirol. 12, 100-107 (Pubitemid 44574601)
49. Wynn, H. E., Brundage, R. C., and Fletcher, C. V. (2002) Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs 16, 595-609 (Pubitemid 34941127)
50. Jones, G., and Power, C. (2006) Regulation of neural cell survival by HIV-1 infection. Neurobiol. Dis. 21, 1-17 (Pubitemid 41817300)
51. Everall, I. P., Heaton, R. K., Marcotte, T. D., Ellis, R. J., McCutchan, J. A., Atkinson, J. H., Grant, I., Mallory, M., and Masliah, E. (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol. 9, 209-217
52. Masliah, E., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Wiley, C. A., Mallory, M., Achim, C. L., McCutchan, J. A., Nelson, J. A., Atkinson, J. H., and Grant, I. (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann. Neurol. 42, 963-972
53. Adle-Biassette, H., Chretien, F., Wingertsmann, L., Hery, C., Ereau, T., Scaravilli, F., Tardieu, M., and Gray, F. (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25, 123-133 (Pubitemid 29221762)
54. Everall, I. P., Glass, J. D., McArthur, J., Spargo, E., and Lantos, P. (1994) Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol. 88, 538-544 (Pubitemid 24364701)
55. Conant, K., McArthur, J. C., Griffin, D. E., Sjulson, L., Wahl, L. M., and Irani, D. N. (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46, 391-398 (Pubitemid 29416277)
56. Ohtani, Y., Minami, M., Kawaguchi, N., Nishiyori, A., Yamamoto, J., Takami, S., and Satoh, M. (1998) Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci. Lett. 249, 163-166 (Pubitemid 28331541)
57. Ventruti, A., and Cuervo, A. M. (2007) Autophagy and neurodegeneration. Curr. Neurol. Neurosci. Rep. 7, 443-451
58. Zhou, D., and Spector, S. A. (2008) Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 22, 695-699
59. Levine, B., and Sodora, D. L. (2006) HIV and CXCR4 in a kiss of autophagic death. J. Clin. Invest. 116, 2078-2080 (Pubitemid 44162313)
60. Klionsky, D. J., and Emr, S. D. (2000) Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721
61. Levine, B., and Kroemer, G. (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42
62. Levine, B., and Klionsky, D. J. (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell. 6, 463-477 (Pubitemid 38456176)
63. Ohsumi, Y. (2001) Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. Cell. Biol. 2, 211-216
64. Tang, G., Yue, Z., Talloczy, Z., Hagemann, T., Cho, W., Messing, A., Sulzer, D. L., and Goldman, J. E. (2008) Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum. Mol. Genet. 17, 1540-1555 (Pubitemid 351737159)